Colony Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$537K Sell
10,175
-134
-1% -$7.03K 0.01% 537
2023
Q2
$558K Sell
10,309
-655
-6% -$34.2K 0.01% 548
2023
Q1
$549K Sell
10,964
-9,001
-45% -$424K 0.01% 549
2022
Q4
$924K Buy
19,965
+10,547
+112% +$457K 0.01% 500
2022
Q3
$365K Sell
9,418
-84
-0.9% -$3.37K 0.01% 629
2022
Q2
$354K Buy
9,502
+84
+0.9% +$3.42K 0.01% 660
2022
Q1
$417K Buy
9,418
+3,045
+48% +$132K 0.01% 664
2021
Q4
$271K Buy
6,373
+700
+12% +$29.4K ﹤0.01% 716
2021
Q3
$246K Hold
5,673
﹤0.01% 749
2021
Q2
$243K Sell
5,673
-48
-0.8% -$2.02K ﹤0.01% 697
2021
Q1
$221K Buy
+5,721
New +$217K ﹤0.01% 707
2020
Q4
Sell
-7,028
Closed -$269K 731
2020
Q3
$269K Sell
7,028
-180
-2% -$6.94K 0.01% 623
2020
Q2
$253K Buy
+7,208
New +$260K 0.01% 591
2020
Q1
Sell
-7,497
Closed -$339K 686
2019
Q4
$339K Buy
+7,497
New +$314K 0.01% 600
2016
Q1
Sell
-830
Closed -$15K 294
2015
Q4
$15K Sell
830
-406
-33% -$7.28K ﹤0.01% 573
2015
Q3
$20K Buy
+1,236
New +$21.1K ﹤0.01% 543
2014
Q4
Sell
-12,505
Closed -$148K 766
2014
Q3
$148K Hold
12,505
0.02% 341
2014
Q2
$160K Hold
12,505
0.02% 232
2014
Q1
$169K Buy
+12,505
New +$164K 0.02% 226

Other funds holding BSX

Colony Group's BSX Position: Q3 2023 in Review

Colony Group reduced its Boston Scientific (BSX) stake by 1.3% in Q3 2023, selling an estimated $7.03K and leaving 10,175 shares worth $537K. The position accounts for 0.01% of the portfolio, ranked #537.

Colony Group first reported a position in BSX in Q1 2014 and has held it in 19 quarters since. The position peaked at $924K in Q4 2022. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Colony Group held 10,175 shares of Boston Scientific worth $537K as of Q3 2023.
  • Colony Group sold 134 Boston Scientific shares in Q3 2023, an estimated $7.03K.
  • Boston Scientific made up 0.01% of Colony Group's portfolio in Q3 2023, its #537 holding.
  • Colony Group first reported a position in Boston Scientific in Q1 2014 and has held it in 19 quarters since.
  • Colony Group's Boston Scientific position peaked at $924K in Q4 2022.
  • 1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.